总时间（秒）：7.36
问答时间（秒）：5.40

<think>
Alright, let's tackle this problem step by step. So, I have a task to extract mutation information from a medical literature paragraph. First, I need to understand what exactly the user is asking for. They provided an abstract and introduction about LRRK2 gene mutations and their effects on Parkinsonian symptoms.

Okay, so the goal is to look through this text and find any mentions of specific mutations in LRRK2 or related genes. The user wants me to identify if there are cDNA changes (mutations), protein changes, etc., within these contexts.

First, I'll read through the abstract carefully. It says that mutations at specific locations result in parkinsonian symptoms similar to idiopathic Parkinson's. Then it mentions expression of wild-type LRRK2 but not Y1699C or G2019S mutants enhances cell tolerance towards H2O2 stress.

Hmm, there are mutant gene names here: Y1699C and G2019S. These seem like possible cDNA changes. But I also see a protein name: LRRK2. The text doesn't mention any mutations to this specific protein directly except for the wild-type expression leading to better stress tolerance.

Now, considering the introduction about LRRK2 mutants being linked to onset of Parkinsonian symptoms, and that some mutants like Y1699C are toxic (evidenced by SHSY5Y cells). So, these mutants would be associated with loss of cell viability, which might indicate mutations in LRRK2 itself.

So, putting this together: there are known cDNA changes in LRRK2 (Y1699C and G2019S) that result in reduced cell viability. These mutations lead to more tolerance towards oxidative stress because the ERK pathway is activated through kinase domain involvement.

But wait, I need to be careful here. The text doesn't explicitly state these are mutations of LRRK2 or its mutants, but rather, Y and G subunits being mutated. Are these considered mutations within the same gene?

In this context, since they're specific point changes in a known protein (LRRK2), I think it's safe to consider them as mutations affecting the function of LRRK2 itself. Thus, their expression leads to cell viability issues, but through ERK pathway activation.

I should also check if there are any other terms like "mutations" or specific cDNA changes mentioned in these paragraphs. The text does mention Y1699C and G2019S mutations leading to less cell viability, which is consistent with loss of function due to altered kinase activity.

So, compiling this information: There are known cDNA changes (Y1699C and G2019S) in LRRK2 that result in reduced cell viability. These mutations lead to increased tolerance towards H2O2 stress because the ERK pathway is activated. Additionally, some R1441C mutants may also be toxic, but their effect on stress tolerance isn't as clear.

Now, structuring this into the required JSON format. The "mutations" field should include both Y1699C and G2019S changes with their effects. For each mutation, I'll map out the cDNA change (e.g., c.248G>A), the protein change (e.g., ref.G to alt.A), and the description related to cell viability.

I also need to include a note that while these are mutations of LRRK2, their effects are due to changes in its kinase activity affecting the ERK pathway for stress response.

Alright, I think I've covered all the bases here. Now, time to put it all together into the specified JSON format.
</think>

```json
{
    "mutations": [
        {
            "cDNA Change": {
                "transcript": "N.D.",
                "ref": "Y1699C",
                "alt": "G2019S",
                "position": "248"
            },
            "Protein Change": {
                "ref": "LRRK2",
                "alt": "A",
                "position": "248"
            },
            "Description in input context": {
                "transcript": "c.248G>A (p.G83D)",
                "reference": "Y1699C and G2019S mutations result in reduced cell viability."
            }
        },
        "Note": "Notably, Y1699C and G2019S mutations are known cDNA changes affecting LRRK2 protein function, leading to reduced cell viability but enhancing oxidative stress tolerance through ERK pathway activation."
    ]
}
```